United Therapeutics (UTHR) Tops Q4 EPS Views
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $493.10 -0.31%
EPS Growth %: -10.1%
Financial Fact:
Selling, general and administrative: 100.1M
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: -10.1%
Financial Fact:
Selling, general and administrative: 100.1M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 adjusted EPS of $3.21, $1.18 better than the analyst estimate of $2.03. Revenue for the quarter came in at $346.4 million versus the consensus estimate of $336.22 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Catalyst Metals Ltd (CYL:AU) PT Lowered to AUD9.25 at UBS
- Credo Technology shares rise on analyst support and conference comments
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
